Attached files
| file | filename |
|---|---|
| EX-10.22 - EX-10.22 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex10d22.htm |
| 10-K - 10-K - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231x10k.htm |
| EX-32.2 - EX-32.2 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex32d2.htm |
| EX-32.1 - EX-32.1 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex31d1.htm |
| EX-23.1 - EX-23.1 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex23d1.htm |
| EX-10.34 - EX-10.34 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex10d34.htm |
| EX-10.33 - EX-10.33 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex10d33.htm |
| EX-10.23 - EX-10.23 - Kiniksa Pharmaceuticals, Ltd. | knsa-20201231xex10d23.htm |
SUBSIDIARIES OF KINIKSA PHARMACEUTICALS, LTD.
The following subsidiaries are owned directly or indirectly by Kiniksa Pharmaceuticals, Ltd.
Legal Name of |
| Jurisdiction of |
Kiniksa Pharmaceuticals Corp. |
| Delaware |
Kiniksa Pharmaceuticals (France) SARL |
| France |
Kiniksa Pharmaceuticals (Germany) GmbH |
| Germany |
Kiniksa Pharmaceuticals GmbH |
| Switzerland |
Kiniksa Pharmaceuticals (UK), Ltd. |
| United Kingdom |
Primatope Therapeutics, Inc. |
| Delaware |